RxDoctor Payments Data

Napoleon Cuenco, MD

Psychiatry · Galax, VANPI 1841237211

Payments from drug & device makers

$1,106in general payments, 2019–2025

Across 60 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$210
  • Alkermes, Inc.$200
  • AbbVie$182
  • Otsuka America Pharmaceutical, Inc.$134
  • E.r. Squibb & Sons, L.L.C.$128
  • Indivior Inc.$61
  • plus $191 from 5 others

What the payments were for

  • Food & beverage$1,106100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,106 in reported general payments places this provider in the 75th percentile of 884 psychiatry providers in Virginia.

See all psychiatry providers in Virginia

Medicare billing

Part B allowed, 2024
$37,574
Medicare patients
83
Services billed
365

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate90$275,085
Invega TrinzaPaliperidone Palmitate26$252,960
Abilify MaintenaAripiprazole79$233,065
VraylarCariprazine Hcl87$121,080
PerserisRisperidone23$66,713
UzedyRisperidone11$32,399
Aripiprazole240$19,077
Risperdal ConstaRisperidone Microspheres14$16,935
Paliperidone ErPaliperidone36$13,976
Divalproex Sodium ErDivalproex Sodium158$9,916
Olanzapine237$9,334
Clozapine72$7,464
Olanzapine OdtOlanzapine33$6,125
Quetiapine Fumarate383$5,680
Ziprasidone Hcl30$4,400

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta$210$544,980130 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$134$233,06579 claims
AbbVieVraylar$182$121,08087 claims
Indivior Inc.Perseris$61$66,71323 claims
Teva Pharmaceuticals USA, Inc.Uzedy$45$32,39911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 884 psychiatry providers in Virginia.

Other psychiatry in Galax

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →